Tau-PET signal in Alzheimer's disease is related to immune activation and synaptic signaling measured with CSF proteomics

被引：0
|
作者：
Van de Giessen, E. [1 ]
Rikken, R. M. [1 ]
Vromen, E. [1 ]
Coomans, E. M. [1 ]
Visser, D. [1 ]
Barkhof, F. [1 ]
Collij, L. E. [1 ]
Boellaard, R. [1 ]
Golla, S. V. S. [1 ]
van Berckel, B. N. M. [1 ]
Ossenkoppele, R. [1 ]
den Braber, A. [1 ]
Vijverberg, J. [1 ]
van der Flier, W. M. [1 ]
Pijnenburg, Y. A. L. [1 ]
Teunissen, C. E. [1 ]
Visser, P. J. [1 ]
Tijms, B. [1 ]
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-109
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [31] Novel CSF β-synuclein-specific assays signal early synaptic degeneration in Alzheimer’s disease
    Sherif Bayoumy
    Julie Goossens
    Charlotte De Rocker
    Senna Y. Sie
    Nolan J. Barrett
    Wiesje M. van der Flier
    Charlotte E. Teunissen
    Eugeen Vanmechelen
    Inge M. W. Verberk
    Alzheimer's Research & Therapy, 17 (1)
  • [32] Bayesian workflow for the investigation of hierarchical classification models from tau-PET and structural MRI data across the Alzheimer's disease spectrum
    Belasso, Clyde J.
    Cai, Zhengchen
    Bezgin, Gleb
    Pascoal, Tharick
    Stevenson, Jenna
    Rahmouni, Nesrine
    Tissot, Cecile
    Lussier, Firoza
    Rosa-Neto, Pedro
    Soucy, Jean-Paul
    Rivaz, Hassan
    Benali, Habib
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [33] Associations between markers of synaptic dysfunction and tau accumulation, glial activation, and neurodegeneration in Alzheimer's disease
    Lussier, Firoza Z.
    Servaes, Stijn
    Tissot, Cecile
    Therriault, Joseph
    Kang, Min-Su
    Bezgin, Gleb
    Chamoun, Mira
    Stevenson, Jenna
    Rahmouni, Nesrine
    Benedet, Andrea L.
    Nilsson, Johanna
    Ashton, Nicholas J.
    Blennow, Kaj
    Brinkmalm, Ann
    Zetterberg, Henrik
    Rosa-Neto, Pedro
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (1_SUPPL): : 149 - 149
  • [34] CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease
    Ceravolo, R.
    Borghetti, D.
    Kiferle, L.
    Tognoni, G.
    Giorgetti, A.
    Neglia, D.
    Sassi, N.
    Frosini, D.
    Rossi, C.
    Petrozzi, L.
    Siciliano, G.
    Murri, L.
    BRAIN RESEARCH BULLETIN, 2008, 76 (1-2) : 80 - 84
  • [35] CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
    Shue, Francis
    White, Launia J.
    Hendrix, Rachel
    Ulrich, Jason
    Henson, Rachel L.
    Knight, William
    Martens, Yuka A.
    Wang, Ni
    Roy, Bhaskar
    Starling, Skylar C.
    Ren, Yingxue
    Xiong, Chengjie
    Asmann, Yan W.
    Syrjanen, Jeremy A.
    Vassilaki, Maria
    Mielke, Michelle M.
    Timsina, Jigyasha
    Sung, Yun Ju
    Cruchaga, Carlos
    Holtzman, David M.
    Bu, Guojun
    Petersen, Ronald C.
    Heckman, Michael G.
    Kanekiyo, Takahisa
    SCIENCE ADVANCES, 2024, 10 (14)
  • [36] Hippocampal subfield imaging and fractional anisotropy show parallel changes in Alzheimer's disease tau progression using simultaneous tau-PET/MRI at 3T
    Carlson, Mackenzie L.
    Toueg, Tyler N.
    Khalighi, M. Mehdi
    Castillo, Jessa
    Shen, Bin
    Azevedo, Emily C.
    DiGiacomo, Phillip
    Mouchawar, Nicole
    Chau, Gustavo
    Zaharchuk, Greg
    James, Michelle L.
    Mormino, Elizabeth C.
    Zeineh, Michael M.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [37] Correlation between neuronal function measured by FDG PET and synaptic density measured by 11C-UCB-J PET in Alzheimer's disease
    Chen, M. K.
    Mecca, A. P.
    Toyonaga, T.
    Mondal, J.
    Naganawa, M.
    Gallezot, J. D.
    Nabulsi, N. B.
    Huang, Y.
    van Dyck, C.
    Carson, R. E.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 568 - 569
  • [38] Coordination chemistry of ligands: Insights into the design of amyloid beta/tau-PET imaging probes and nanoparticles-based therapies for Alzheimer's disease
    Selvan, Subramanian Tamil
    Ravichandar, Roopa
    Ghosh, Krishna Kanta
    Mohan, Anand
    Mahalakshmi, Pachaiyappan
    Gulyas, Balazs
    Padmanabhan, Parasuraman
    COORDINATION CHEMISTRY REVIEWS, 2021, 430
  • [39] Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease
    Del Percio, Claudio
    Lizio, Roberta
    Lopez, Susanna
    Noce, Giuseppe
    Carpi, Matteo
    Jakhar, Dharmendra
    Soricelli, Andrea
    Salvatore, Marco
    Yener, Goersev
    Guntekin, Bahar
    Massa, Federico
    Arnaldi, Dario
    Fama, Francesco
    Pardini, Matteo
    Ferri, Raffaele
    Carducci, Filippo
    Lanuzza, Bartolo
    Stocchi, Fabrizio
    Vacca, Laura
    Coletti, Chiara
    Marizzoni, Moira
    Taylor, John Paul
    Hanoglu, Lutfu
    Yilmaz, Nesrin Helvaci
    Kiyi, Ilayda
    Ozbek-Isbitiren, Yagmur
    D'Anselmo, Anita
    Bonanni, Laura
    Biundo, Roberta
    D'Antonio, Fabrizia
    Bruno, Giuseppe
    Antonini, Angelo
    Giubilei, Franco
    Farotti, Lucia
    Parnetti, Lucilla
    Frisoni, Giovanni B.
    Babiloni, Claudio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
  • [40] Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study
    Julien Lagarde
    Pauline Olivieri
    Matteo Tonietto
    Sébastian Rodrigo
    Philippe Gervais
    Fabien Caillé
    Martin Moussion
    Michel Bottlaender
    Marie Sarazin
    Alzheimer's Research & Therapy, 15
12345